As interest in psychedelic therapies continues to grow across California and throughout the United States, more people are encountering the term psychedelic-assisted therapy. While the phrase is increasingly common in research studies, news coverage, and mental health discussions, many people are unsure what it actually means.
Psychedelic-assisted therapy refers to a structured therapeutic approach that combines the use of a psychedelic substance with professional psychological support before, during, and after the experience. Rather than focusing solely on the psychedelic itself, the model emphasizes preparation, guidance, integration, and the broader therapeutic process.
Researchers are currently studying psychedelic-assisted therapy for a variety of mental health conditions, including PTSD, depression, anxiety disorders, and emotional distress related to serious illness. While several treatment models are showing promise, most remain in research settings or are awaiting further regulatory review.
What Does Psychedelic-Assisted Therapy Involve?
Although protocols vary depending on the substance being studied, most psychedelic-assisted therapy models include three core phases:
Preparation
Preparation occurs before any psychedelic experience takes place. During this phase, individuals meet with therapists or clinical staff to discuss goals, review medical and mental health history, learn about the treatment process, and establish trust with the treatment team.
Preparation is considered one of the most important aspects of the therapeutic process. Research suggests that expectations, mindset, and emotional readiness can significantly influence a person’s experience.
The Psychedelic Session
The treatment session itself generally takes place in a structured and carefully monitored environment. Depending on the protocol being used, participants may spend several hours working with trained clinicians while under the effects of the psychedelic substance.
Unlike recreational use, psychedelic-assisted therapy is not designed around entertainment or intoxication. The focus is typically on therapeutic exploration, emotional processing, and psychological insight.
Integration
Integration refers to the process of making sense of thoughts, emotions, memories, or insights that emerge during a psychedelic experience.
Many researchers and clinicians consider integration to be one of the most important components of psychedelic-assisted therapy. Without integration, meaningful experiences may not translate into lasting behavioral or emotional change.
Individuals may continue meeting with therapists after treatment sessions to discuss what occurred, identify themes, and apply insights to everyday life.
For those interested in learning more about this process, our guide to psychedelic integration therapy explores the topic in greater depth.
How Is Psychedelic-Assisted Therapy Different From Integration Therapy?
Psychedelic-assisted therapy and integration therapy are related but distinct concepts.
Psychedelic-assisted therapy includes the entire treatment process, including preparation, the psychedelic session itself, and integration afterward.
Integration therapy focuses specifically on helping individuals process and understand psychedelic experiences. Some people seek integration therapy after participating in a clinical trial, receiving ketamine treatment, or even after a previous psychedelic experience that occurred outside of a clinical setting.
In other words, integration therapy can be one component of psychedelic-assisted therapy, but it can also exist independently.
How Is Psychedelic-Assisted Therapy Different From Recreational Psychedelic Use?
One of the most common misconceptions is that psychedelic-assisted therapy is simply recreational psychedelic use occurring in a therapeutic office.
In reality, the two approaches are fundamentally different.
Recreational use typically occurs outside of a structured clinical framework and may not include screening, preparation, therapeutic support, or integration afterward.
Psychedelic-assisted therapy, by contrast, is built around safety protocols, therapeutic goals, professional oversight, and ongoing support.
Researchers believe that these factors may play an important role in treatment outcomes and participant safety.
How Is Psychedelic-Assisted Therapy Different From Ketamine Therapy?
Ketamine therapy is often discussed alongside psychedelic-assisted therapy, but ketamine occupies a unique position within the field.
Ketamine is a dissociative medication that is already legally available through licensed medical providers in California. Certain forms of ketamine treatment are FDA-approved, while others may be prescribed under medical supervision for specific conditions.
MDMA and psilocybin, on the other hand, are still primarily being studied through clinical research programs and have not yet achieved the same level of regulatory availability.
Despite these differences, ketamine therapy often incorporates similar concepts, including preparation, therapeutic support, and integration.
Many clinicians view ketamine as part of the broader conversation surrounding psychedelic-informed mental health care.
What Conditions Are Researchers Studying?
Researchers around the world are currently investigating psychedelic-assisted therapy for a variety of mental health and medical conditions.
Some of the most active areas of research include:
PTSD
MDMA-assisted therapy has received significant attention for its potential role in treating post-traumatic stress disorder. Clinical studies have examined whether combining psychotherapy with MDMA may help individuals process traumatic experiences in new ways.
Depression
Psilocybin-assisted therapy is being studied extensively for treatment-resistant depression and major depressive disorder. Researchers continue to investigate how psychedelic experiences may influence mood, cognition, and emotional flexibility.
Anxiety
Several psychedelic therapies are being explored for anxiety disorders, particularly when traditional treatments have not provided sufficient relief.
End-of-Life Distress
Researchers have also examined psychedelic-assisted therapies for individuals facing serious illness, terminal diagnoses, or existential distress. Some studies suggest these approaches may help reduce anxiety and improve quality of life in certain situations.
MDMA-Assisted Therapy vs. Psilocybin-Assisted Therapy
Although both fall under the umbrella of psychedelic-assisted therapy, MDMA and psilocybin work differently and are being studied for somewhat different purposes.
MDMA-assisted therapy has been most closely associated with PTSD research and trauma-focused treatment models.
Psilocybin-assisted therapy has received substantial attention for depression, anxiety, and broader emotional well-being.
Both approaches typically involve structured preparation, guided sessions, and integration afterward, but the therapeutic experiences themselves may differ significantly.
Is Psychedelic-Assisted Therapy Legal in California?
The legal status of psychedelic-assisted therapy in California depends on the specific substance being discussed.
Ketamine therapy is currently available through licensed medical providers.
MDMA-assisted therapy and psilocybin-assisted therapy remain largely limited to clinical trials, research settings, and future regulatory pathways. Laws and regulations continue to evolve, making it important to verify current information through reliable sources and licensed healthcare professionals.
Individuals interested in learning more about available opportunities may wish to explore current psychedelic clinical trials in California and ongoing developments within the field.
The Future of Psychedelic-Assisted Therapy
Interest in psychedelic-assisted therapy continues to grow as researchers, clinicians, and policymakers explore its potential role in mental health treatment.
While many questions remain, one principle consistently appears throughout the research: psychedelic substances alone are rarely viewed as the treatment. Rather, the therapeutic framework surrounding preparation, professional support, and integration is considered a central component of the process.
As research advances, psychedelic-assisted therapy is likely to remain an important area of discussion within mental health care, neuroscience, and behavioral health throughout California and beyond.